CBL and lymphoid neoplasm: Mutations of c-CBL have been reported in a few myeloid and lymphoid neoplasms [10], and there is limited evidence suggesting that disruption of c-CBL function may contribute to the pathogenesis of other solid tumors as well [11–15].